Detalhe da pesquisa
1.
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer Treatment.
Oncologist
; 28(3): e145-e155, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719033